Procalcitonin and Midregional Proatrial Natriuretic Peptide as Markers of Ischemic Stroke | Zendy

Mira Katan | Zendy; Yeseon Park Moon | Zendy; Myunghee Cho Paik | Zendy; Beat Müeller | Zendy; Andreas Huber | Zendy; Ralph L. Sacco | Zendy; Mitchell S.V. Elkind | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Procalcitonin and Midregional Proatrial Natriuretic Peptide as Markers of Ischemic Stroke

Author(s) -

Mira Katan,

Yeseon Park Moon,

Myunghee Cho Paik,

Beat Müeller,

Andreas Huber,

Ralph L. Sacco,

Mitchell S.V. Elkind

Publication year - 2016

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.115.011392

Subject(s) - medicine , copeptin , stroke (engine) , quartile , cardiology , procalcitonin , hazard ratio , brain natriuretic peptide , natriuretic peptide , proportional hazards model , confidence interval , heart failure , mechanical engineering , engineering , vasopressin , sepsis

Chronic infections and neuroendocrine dysfunction may be risk factors for ischemic stroke (IS). We hypothesized that selected blood biomarkers of infection (procalcitonin [PCT]), hypothalamic-pituitary-axis function (copeptin), and hemodynamic dysfunction (midregional proatrial natriuretic peptide [MRproANP]) are associated with incident IS risk in the multiethnic, urban Northern Manhattan Study (NOMAS) cohort.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research